182 related articles for article (PubMed ID: 20576718)
1. Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulation. a report from the Children's Oncology Group.
Arndt CA; Koshkina NV; Inwards CY; Hawkins DS; Krailo MD; Villaluna D; Anderson PM; Goorin AM; Blakely ML; Bernstein M; Bell SA; Ray K; Grendahl DC; Marina N; Kleinerman ES
Clin Cancer Res; 2010 Aug; 16(15):4024-30. PubMed ID: 20576718
[TBL] [Abstract][Full Text] [Related]
2. Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases.
Anderson PM; Markovic SN; Sloan JA; Clawson ML; Wylam M; Arndt CA; Smithson WA; Burch P; Gornet M; Rahman E
Clin Cancer Res; 1999 Sep; 5(9):2316-23. PubMed ID: 10499599
[TBL] [Abstract][Full Text] [Related]
3. Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943.
Seibel NL; Krailo M; Chen Z; Healey J; Breitfeld PP; Drachtman R; Greffe B; Nachman J; Nadel H; Sato JK; Meyers PA; Reaman GH
Cancer; 2007 Apr; 109(8):1646-53. PubMed ID: 17334983
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma.
Kleinerman ES; Gano JB; Johnston DA; Benjamin RS; Jaffe N
Am J Clin Oncol; 1995 Apr; 18(2):93-9. PubMed ID: 7900714
[TBL] [Abstract][Full Text] [Related]
5. Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group.
Hingorani P; Krailo M; Buxton A; Hutson P; Sondel PM; Diccianni M; Yu A; Morris CD; Womer RB; Crompton B; Randall RL; Teot LA; DuBois SG; Janeway KA; Gorlick RG; Isakoff MS
Eur J Cancer; 2022 Sep; 172():264-275. PubMed ID: 35809374
[TBL] [Abstract][Full Text] [Related]
6. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.
Lewis IJ; Nooij MA; Whelan J; Sydes MR; Grimer R; Hogendoorn PC; Memon MA; Weeden S; Uscinska BM; van Glabbeke M; Kirkpatrick A; Hauben EI; Craft AW; Taminiau AH; ;
J Natl Cancer Inst; 2007 Jan; 99(2):112-28. PubMed ID: 17227995
[TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
8. Should contralateral exploratory thoracotomy be advocated for children with osteosarcoma and early unilateral pulmonary metastases?
Karplus G; McCarville MB; Smeltzer MP; Spyridis G; Rao BN; Davidoff A; Li CS; Shochat S
J Pediatr Surg; 2009 Apr; 44(4):665-71. PubMed ID: 19361624
[TBL] [Abstract][Full Text] [Related]
9. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival.
Ferrari S; Briccoli A; Mercuri M; Bertoni F; Picci P; Tienghi A; Del Prever AB; Fagioli F; Comandone A; Bacci G
J Clin Oncol; 2003 Feb; 21(4):710-5. PubMed ID: 12586810
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.
Lagmay JP; Krailo MD; Dang H; Kim A; Hawkins DS; Beaty O; Widemann BC; Zwerdling T; Bomgaars L; Langevin AM; Grier HE; Weigel B; Blaney SM; Gorlick R; Janeway KA
J Clin Oncol; 2016 Sep; 34(25):3031-8. PubMed ID: 27400942
[TBL] [Abstract][Full Text] [Related]
11. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
[TBL] [Abstract][Full Text] [Related]
12. Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung.
Chou AJ; Gupta R; Bell MD; Riewe KO; Meyers PA; Gorlick R
Pediatr Blood Cancer; 2013 Apr; 60(4):580-6. PubMed ID: 23255417
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
14. Aerosolized granulocyte macrophage colony-stimulating factor (GM-CSF) therapy in metastatic cancer.
Rao RD; Anderson PM; Arndt CA; Wettstein PJ; Markovic SN
Am J Clin Oncol; 2003 Oct; 26(5):493-8. PubMed ID: 14528078
[TBL] [Abstract][Full Text] [Related]
15. Caffeine-potentiated chemotherapy for metastatic osteosarcoma.
Kimura H; Tsuchiya H; Shirai T; Nishida H; Hayashi K; Takeuchi A; Ohnari I; Tomita K
J Orthop Sci; 2009 Sep; 14(5):556-65. PubMed ID: 19802667
[TBL] [Abstract][Full Text] [Related]
16. Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children's Research Hospital experience.
Leary SE; Wozniak AW; Billups CA; Wu J; McPherson V; Neel MD; Rao BN; Daw NC
Cancer; 2013 Jul; 119(14):2645-53. PubMed ID: 23625626
[TBL] [Abstract][Full Text] [Related]
17. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.
Goorin AM; Harris MB; Bernstein M; Ferguson W; Devidas M; Siegal GP; Gebhardt MC; Schwartz CL; Link M; Grier HE
J Clin Oncol; 2002 Jan; 20(2):426-33. PubMed ID: 11786570
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
Harting MT; Blakely ML; Jaffe N; Cox CS; Hayes-Jordan A; Benjamin RS; Raymond AK; Andrassy RJ; Lally KP
J Pediatr Surg; 2006 Jan; 41(1):194-9. PubMed ID: 16410132
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas.
Poiré X; Kline J; Grinblatt D; Zimmerman T; Conner K; Muhs C; Gajewski T; Van Besien K; Smith SM
Leuk Lymphoma; 2010 Jul; 51(7):1241-50. PubMed ID: 20496994
[TBL] [Abstract][Full Text] [Related]
20. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis.
Wylam ME; Ten R; Prakash UB; Nadrous HF; Clawson ML; Anderson PM
Eur Respir J; 2006 Mar; 27(3):585-93. PubMed ID: 16507860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]